Sherry Group’s Annovis Bio ANVS Stock Holding History

Sherry Group’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107K	Hold	57,270	–	–	0.1%	51
2026 Q1	$128K	Buy	57,270 +30,000	+110%	+$82.3K	0.14%	40
2025 Q4	$94.4K	Buy	+27,270	New	+$82K	0.1%	43

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Sherry Group's ANVS Position: Q2 2026 in Review

Sherry Group held its Annovis Bio (ANVS) position steady in Q2 2026 at 57,270 shares worth $107K. The position accounts for 0.1% of the portfolio, ranked #51.

Sherry Group first reported a position in ANVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $128K in Q1 2026. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Sherry Group held 57,270 shares of Annovis Bio worth $107K as of Q2 2026.
Sherry Group left its Annovis Bio share count unchanged in Q2 2026.
Annovis Bio made up 0.1% of Sherry Group's portfolio in Q2 2026, its #51 holding.
Sherry Group first reported a position in Annovis Bio in Q4 2025 and has held it in 3 quarters since.
Sherry Group's Annovis Bio position peaked at $128K in Q1 2026.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Sherry Group's 13F filing for Q2 2026, filed 16 Jul 2026.